Serum selenium and selenoprotein-P levels in autoimmune thyroid diseases patients in a select center: a transversal study.

Journal: Archives of endocrinology and metabolism
PMID: 29412385

Abstract

OBJECTIVE: Selenium (Se) supplementation has been used to help prevent the progression of Graves' ophthalmopathy (GO) and autoimmune thyroid diseases (AITD) patients. We investigated Se serum and selenoprotein P (SePP) levels in Graves' disease (GD) with and without GO, Hashimoto's thyroiditis (HT) patients and in 27 control individuals (C).

Authors

  • Marco Aurélio Ferreira Federige
    Endocrinología, Hospital do Servidor Público Estadual (IAMSPE), São Paulo, SP Brasil.
  • João Hamilton Romaldini
    Endocrinología, Hospital do Servidor Público Estadual (IAMSPE), São Paulo, SP Brasil.
  • Ana Beatriz Pinotti Pedro Miklos
    Endocrinología, Hospital do Servidor Público Estadual (IAMSPE), São Paulo, SP Brasil.
  • Marcia Kiyomi Koike
    Endocrinología, Hospital do Servidor Público Estadual (IAMSPE), São Paulo, SP Brasil.
  • Kioko Takei
    Endocrinología, Hospital do Servidor Público Estadual (IAMSPE), São Paulo, SP Brasil.
  • Evandro de Souza Portes
    Endocrinología, Hospital do Servidor Público Estadual (IAMSPE), São Paulo, SP Brasil.

Keywords

External Resources

Popular Topics
Recent Journals